The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,108.00
Bid: 1,108.00
Ask: 1,110.00
Change: 8.00 (0.73%)
Spread: 2.00 (0.181%)
Open: 1,128.00
High: 1,128.00
Low: 1,100.00
Prev. Close: 1,100.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Jun 2020 16:52

RNS Number : 5981R
Savills PLC
30 June 2020
 

SAVILLS PLC (THE 'COMPANY')

NOTIFICATION OF INTERESTS OF DIRECTORS/ PERSONS DISCHARGING MANAGERIAL RESPONSIBILIES ('PDMRS')

 

Grant of Share Awards

 

The Company announces that on 30 June 2020 awards have been made under The Savills plc Performance Share Plan (the "Performance Share Plan") to Directors and PDMRS of the Company as follows:

 

Director / PDMR

Number of Shares subject to the Performance Share Plan awarded to the Director / PDMR on 30 June 2020

Total number of shares subject to the Performance Share Plan following this notification

Mark Ridley (Director)

70,828

200,658

Simon Shaw (Director)

54,141

171,401

Chris Lee (PDMR)

27,551

82,205

 

The Performance Share Plan provides for the award of nil cost options or conditional awards of ordinary shares in the Company.

Awards of shares are made subject to a three-year performance period. Awards which satisfy the applicable performance criteria (as below) in the three-year performance period will then vest after an additional two-year holding period.

Awards vest subject to the satisfaction of the following performance criteria measured over the three years following grant:

(a) one-third of the initial value of an award is subject to the Company's Total Shareholder Return ('TSR') performance measured against the TSR of the FTSE Mid 250 Index (excluding investment trusts);

(b) a further one-third of the initial value of an award is subject to real (i.e. growth in excess of RPI) Group Earnings per Share ('EPS') growth performance; and

(c) the final one-third of the initial value of an award is subject to the Return on Equity ('ROE') targets, with ROE defined as underlying profit before tax divided by average ordinary shareholders' equity measured over the three-year performance period.

Awards vest as follows:

(a) for the TSR linked part of an award, 25% (i.e. threshold) will vest if the Company's TSR matches Index performance, rising to 100% (i.e. maximum) if the Company's TSR outperforms the Index by 8% p.a., compound with sliding scale vesting between the two points;

(b) for the EPS growth linked part of an award, 25% (i.e. threshold) will vest if the Company's real EPS growth (i.e. growth in excess of RPI) is 3% p.a., compound rising to 100% (i.e. maximum) if the Company's real (i.e. growth in excess of RPI) EPS growth is 8% p.a., compound with sliding scale vesting between the two points; and

(c) for the ROE linked part of an award, 25% (i.e. threshold) will vest if the Company's ROE is 24%, rising to 100% (i.e. maximum) if the Company's ROE is 32.5% or more; and with straight-line vesting between the two points.

We acknowledge that, in common with many other companies we have seen a fall in our share price since the end of February as a result of the coronavirus pandemic. Under the rules of the Performance Share Plan, the Remuneration Committee has full discretion to ensure that the final outturns reflect all relevant factors, including consideration of any windfall gains.

 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the person discharging managerial responsibilities/ person closely associated

 

(a)

Name

1. Mark Ridley

2. Simon Shaw

3. Chris Lee

 

2.

Reason for the notification

 

(a)

Position/ status

1. Group Chief Executive/ Director

2. Group Chief Financial Officer/ Director

3. Group Legal Director and Company Secretary/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Grant of awards over Ordinary Shares in accordance with the Company's Performance Share Plan

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£nil per share

1. 70,828

2. 54,141

3. 27,551

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

30 June 2020

(g)

Place of the transaction

 

Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

30 June 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKZGFVKGGGGZM
Date   Source Headline
15th Mar 20187:00 amRNSFinal Results
13th Mar 20185:21 pmRNSDirector/PDMR Shareholding
13th Feb 20183:04 pmRNSDirector/PDMR Shareholding
22nd Jan 201810:00 amRNSBlock listing Interim Review
16th Jan 20187:00 amRNSSavills Announces Succession Plan
16th Jan 20187:00 amRNSPre-close Trading Update
11th Jan 20184:31 pmRNSDirector/PDMR Shareholding
2nd Jan 20187:00 amRNSTotal Voting Rights
29th Dec 201712:17 pmRNSCompletion of Acquisition
14th Dec 201712:44 pmRNSDirector/PDMR Shareholding
13th Nov 20173:16 pmRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSTotal Voting Rights
12th Oct 20179:41 amRNSDirector/PDMR Shareholding
9th Oct 20179:27 amRNSHolding(s) in Company
3rd Oct 201712:00 pmRNSIssue of Equity
12th Sep 20174:38 pmRNSDirector/PDMR Shareholding
1st Sep 20177:00 amRNSTotal Voting Rights
24th Aug 20179:53 amRNSHolding(s) in Company
15th Aug 20174:28 pmRNSBlock listing Interim Review
15th Aug 20179:18 amRNSDirector/PDMR Shareholding
15th Aug 20178:58 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSHalf-year Report
28th Jul 201712:20 pmRNSAcquisition
18th Jul 201712:00 pmRNSIssue of Equity
11th Jul 20175:00 pmRNSDirector/PDMR Shareholding
30th Jun 20177:00 amRNSHolding(s) in Company
13th Jun 20173:12 pmRNSDirector/PDMR Shareholding
12th Jun 20175:55 pmRNSHolding(s) in Company
5th Jun 20172:57 pmRNSHolding(s) in Company
5th Jun 201710:24 amRNSHolding(s) in Company
1st Jun 20173:21 pmRNSDirector/PDMR Shareholding
24th May 201711:00 amRNSIssue of Equity
22nd May 201712:25 pmRNSDirector/PDMR Shareholding
18th May 201711:20 amRNSDirector/PDMR Shareholding
17th May 20175:00 pmRNSDirector/PDMR Shareholding
15th May 20174:14 pmRNSDirector/PDMR Shareholding
11th May 20172:07 pmRNSDirector/PDMR Shareholding
9th May 20174:31 pmRNSAGM Special Business
9th May 20174:30 pmRNSResult of AGM
9th May 201710:30 amRNSAGM Statement
2nd May 20177:00 amRNSTotal Voting Rights
24th Apr 201712:36 pmRNSDirector/PDMR Shareholding
18th Apr 20172:48 pmRNSDirector/PDMR Shareholding
11th Apr 20174:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20172:50 pmRNSAnnual Report and AGM Notice
3rd Apr 201712:00 pmRNSIssue of Equity
3rd Apr 20177:00 amRNSTotal Voting Rights
24th Mar 20179:30 amRNSDirector/PDMR Shareholding
22nd Mar 20177:00 amRNSFinal Results
13th Mar 20172:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.